CA-A Cancer Journal for Clinicians

Papers
(The H4-Index of CA-A Cancer Journal for Clinicians is 42. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Minority groups underrepresented in hematologic cancer trials12911
Breast cancer in a transgender man12663
Cancer treatment and survivorship statistics, 202512295
Evolution of community outreach and engagement at National Cancer Institute‐Designated Cancer Centers, an evolving journey6459
Antibody–drug conjugates: Smart chemotherapy delivery across tumor histologies1976
Issue Information1931
Highlighting American Cancer Society‐funded research in CA: A Cancer Journal for Clinicians1547
Near majority of adults favor R ratings for films with smoking889
499
Cancer care for transgender and gender‐diverse people: Practical, literature‐driven recommendations from the Multinational Association of Supportive Care in Cancer434
Cancer statistics 2024: All hands on deck359
Breast cancer: The good, the bad, and an important call to effective risk reduction strategies313
Current treatment and future directions in the management of anal cancer281
Most patients with cancer are not undergoing germline genetic testing277
Reirradiation: Standards, challenges, and patient‐focused strategies across tumor types263
Multicancer detection tests: What we know and what we don’t know240
Issue Information223
184
Underrepresentation of Hispanic women in science, technology, engineering, mathematics, and medicine175
Treating EGFR‐mutant nonsmall cell lung cancer is no longer a one‐size‐fits‐all approach162
Reviewer acknowledgement 2025161
Clinical practice guideline and expert consensus recommendations for rehabilitation among children with cancer: A systematic review152
The evolving landscape of tissue‐agnostic therapies in precision oncology109
More care needed for cancer caregivers97
Advances in pancreatic cancer early diagnosis, prevention, and treatment: The past, the present, and the future89
Magnetic resonance linear accelerator technology and adaptive radiation therapy: An overview for clinicians85
Health insurance status and cancer stage at diagnosis and survival in the United States84
Reduced‐volume radiotherapy versus conventional‐volume radiotherapy after induction chemotherapy in nasopharyngeal carcinoma: An open‐label, noninferiority, multicenter, randomized phase 3 trial82
Study identifies risk factors that may lead to secondary cancers80
Overlooked barriers to implementation of geriatric assessment79
Does distance deter male fertility preservation?79
Prostate cancer statistics, 202571
Multidisciplinary management in the treatment of intrahepatic cholangiocarcinoma70
Medicaid expansion increases survival for patients with cancer69
Lung cancer screening guidelines: Smoking matters, not quitting68
The contemporary management of cancers of the sinonasal tract in adults68
Cancer survivors at greater risk for bone fractures late in life61
Interventional gastroenterology in oncology61
Issue Information55
Screening for lung cancer53
Bilateral mastectomy may not reduce mortality risk48
Issue Information44
0.023825883865356